Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGuerra, Manuel
dc.contributor.authorHaye, María Teresa
dc.contributor.authorMontaño, Ignacio
dc.contributor.authorToro, Victoria
dc.contributor.authorMaiz, Nerea
dc.date.accessioned2025-10-31T07:59:30Z
dc.date.available2025-10-31T07:59:30Z
dc.date.issued2025-11
dc.identifier.citationGuerra M; Haye MT, Montaño I, Toro V, Maiz N. Fetal TEI Index in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study. Am J Perinatol. 2025 Nov;42(15):2032-2037.
dc.identifier.issn0735-1631
dc.identifier.urihttp://hdl.handle.net/11351/13992
dc.descriptionIntrahepatic cholestasis of pregnancy; Bile acids; Ursodeoxycholic acid
dc.description.abstractObjectives First, to explore differences in fetal cardiac function in patients with and without intrahepatic cholestasis of pregnancy (ICP) based on the TEI index. Second, to explore a potential correlation between TEI index and bile acid levels in pregnant women with ICP. Third, to study changes in the TEI index of fetuses from pregnant women with ICP after administration of ursodeoxycholic acid (UDCA). Study Design This is a prospective observational case-control study conducted at Hospital Clínico San José and Clínica RedSalud Vitacura, both in Santiago, Chile, between April 2018 and October 2020. ICP was defined as palmar-plantar pruritus of nocturnal predominance for more than 1 week associated with a total bile acid level above 10 μmol/L. Control cases were women with pregnancies scheduled for induction or elective cesarean section between 37 and 40 weeks of gestation according to current protocols. Differences in the TEI index between cases and controls were assessed by the Wilcoxon test. The correlation between the TEI index and bile acid levels was assessed by the Spearman correlation test. Changes in TEI index before and after administration of UDCA were analyzed by the paired samples Wilcoxon test. Results A total of 181 pregnant women were included in the study, 109 women with ICP and 72 controls. The median gestational age at inclusion was 35.9 weeks (interquartile range [IQR], 33.0–38.9). The median TEI index was 0.31 (IQR, 0.29–0.36); this was significantly longer in fetuses of women with ICP ([0.34, IQR, 0.30–0.38] vs. [0.30, IQR, 0.28–0.31], p < 0.001). There was a significant correlation between bile acid levels and TEI index (0.584, p < 0.001). In 21 fetuses, the TEI index was measured a second time, 2 weeks later, following UDCA administration. The median TEI index decreased significantly following UDCA administration (0.40 ms before treatment [IQR, 0.36–0.42] vs. 0.33 after treatment [IQR, 0.32–0.38], p = 0.001), p = 0.001). Conclusion The TEI index is increased in fetuses of women with ICP. TEI index was significantly correlated with bile acid levels, and administration of UDCA significantly reduced the TEI index.
dc.language.isoeng
dc.publisherThieme
dc.relation.ispartofseriesAmerican Journal of Perinatology;42(15)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectColèstasi - Tractament
dc.subjectPosologia
dc.subjectÀcids biliars - Ús terapèutic
dc.subjectEmbaràs - Complicacions
dc.subject.meshCholestasis, Intrahepatic
dc.subject.mesh/drug therapy
dc.subject.meshPregnancy Complications
dc.subject.meshUrsodeoxycholic Acid
dc.subject.mesh/administration & dosage
dc.titleFetal TEI Index in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1055/a-2555-3684
dc.subject.decscolestasis intrahepática
dc.subject.decs/farmacoterapia
dc.subject.decscomplicaciones del embarazo
dc.subject.decsácido ursodesoxicólico
dc.subject.decs/administración & dosificación
dc.relation.publishversionhttps://doi.org/10.1055/a-2555-3684
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Guerra M] Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile. Departament of Perinatology, Clínica Redsalud Vitacura, Santiago, Chile. Escola de Doctorat, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Haye MT] Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile. Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Clínica Alemana. Santiago, Chile. [Montaño I] Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile. Department of Ultrasonography, Clínica Indisa. Santiago, Chile. [Toro V] Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile. [Maiz N] Unitat de Medicina Fetal, Servei d’Obstetrícia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain
dc.identifier.pmid40112872
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record